Neuronata-R Retains Conditional Approval In South Korea
Neuronata-R retains its conditional approval in South Korea, allowing continued clinical use under specific conditions, with further evaluation pending.
Trump Media has reached settlements to resolve ongoing legal disputes, ending multiple lawsuits. Details of the agreements are not yet fully disclosed.
4DMT Announces Positive 2-Year Data From PRISM Phase 2B Clinical Trial In A Broad Wet AMD Population
4DMT announces promising 2-year results from its PRISM Phase 2b clinical trial in wet AMD, indicating potential efficacy of its investigational therapy.
The Hidden Skill in AI: Finishing What It Starts in Business Crises
Discover why AI’s real strength lies in execution, not just conversation. A live experiment shows only disciplined models finish the job, a lesson vital for personal finance tools.
Vireo Growth Inc. Completes Acquisition Of Pennsylvania Dispensary License Transaction
Vireo Growth Inc. has finalized the purchase of a Pennsylvania dispensary license, expanding its operational footprint in the state. Details of the deal are confirmed.
